Flow Forward Medical Inc.
Latest From Flow Forward Medical Inc.
The most desirable form of vascular access for most hemodialysis patients is an arteriovenous fistula (AVF). Flow Forward believes it can expand the AVF prevalence rate to 90% with its Arteriovenous Fistula Eligibility (AFE) System, a temporary external blood pump that rapidly dilates peripheral veins prior to AVF surgery.
In this month's issue of Start-Up, we profile Flow Forward, Intensity Therapeutics, Perimeter Medical Imaging, PhageTech and Pulmotect.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.